Related Experiment Video
Updated: May 23, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Serum protein microarray analysis of patients with preeclampsia
1Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, PR China.
Molecular Medicine Reports
|April 17, 2012
Summary
This study found higher levels of tumor necrosis factor receptor 1 (sTNF-R1) and Axl in preeclampsia patients. These novel biomarkers may indicate inflammatory response and endothelium activation in preeclampsia pathogenesis.
Area of Science:
- Biochemistry
- Immunology
- Obstetrics
Background:
- Preeclampsia is a serious pregnancy complication.
- Identifying reliable biomarkers for preeclampsia is crucial for early diagnosis and management.
Purpose of the Study:
- To identify novel serum biomarkers associated with preeclampsia.
- To investigate the role of specific cytokines in preeclampsia pathogenesis.
Main Methods:
- Serum samples from healthy pregnant subjects, gestational hypertensive patients, and preeclampsia patients were analyzed using human cytokine microarrays.
- Key cytokine levels, including tumor necrosis factor receptor 1 (sTNF-R1), Axl, and TIMP-2, were further validated using sandwich enzyme-linked immunosorbent assay (ELISA).
Main Results:
- Microarray analysis revealed significantly elevated levels of sTNF-R1, Axl, and TIMP-2 in preeclampsia patients compared to controls.
- ELISA confirmed significantly higher serum sTNF-R1 and Axl levels in preeclampsia patients.
- While TIMP-2 levels were higher in preeclampsia patients, the difference was not statistically significant across all groups.
Conclusions:
- Serum sTNF-R1 and Axl are potential novel biomarkers for preeclampsia.
- Elevated levels of these factors suggest involvement of inflammatory response and endothelium activation in preeclampsia.
- Further research is warranted to explore their diagnostic and prognostic value.
Related Concept Videos
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...